Nina Kadan-Lottick, MD

Associate Professor of Pediatrics (Hematology / Oncology); Medical Director, HEROS Program

Clinical Interests

  • Brain Neoplasms
  • Hematologic Diseases
  • Leukemia
  • Medical Oncology
  • Thrombocytopenia

Patient Care

Accepts new patients? Yes
Patient Type: Child
Referrals: From patients or physicians

Patient Care Organizations

Cancer Center, Yale: Hematology Program | Pediatric Hematology & Oncology Program | Supportive Oncology Program

Pediatrics: Pediatric Hematology & Oncology: HEROS Survivorship Clinic | Pediatric Specialty Center

Survivorship Clinic

Yale Medical Group

Board Certifications

  • Pediatric Hematology-Oncology AB of Pediatrics (2000)

Clinical Trials

Conditions Study Title
Bones and Joints, Brain and Nervous System, Kidney, Lymphoid Leukemia, Other Male Genital Exercise Intervention Program: Feasibility Study
Umbrella Long-Term Follow-Up Protocol (COG ALTE05N1) (CIRB)
Lymphoid Leukemia Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children with Cancer (COG ALTE07C1) (CIRB)
Unknown Sites Key Adverse Events after Childhood Cancer (COG ALTE03N1)
Ill-Defined Sites The Connecticut HEROS Registry
Lymphoid Leukemia Treatment of Patients with Newly Diagnosed Standard Risk B-Precursor Acute Lymphoblastic Leukemia (AALL0932) (CIRB)
Soft Tissue Phase III Randomized Trial of Adding Vincristine-Topotecan-Cyclophosphamide to Standard Chemotherapy in Initial Treatment of Non-Metastatic Ewing Sarcoma (COG AEWS1031)(CIRB)
Brain and Nervous System Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed Ependymoma Ages 1 to 21 Years (COG ACNS0831) (CIRB)
Liver Treatment of Children with All Stages of Hepatoblastoma: A Groupwide, Phase III Study (COG AHEP0731) (CIRB)
Bones and Joints, Brain and Nervous System, Hodgkin's Lymphoma, Kidney, Leukemia, not otherwise specified, Leukemia, other, Lymphoid Leukemia, Myeloid and Monocytic Leukemia, Non-Hodgkin's Lymphoma, Other Male Genital, Soft Tissue Protocol for the Enrollment on the Official COG Registry, The Childhood Cancer Network (COG ACCRN07) (CIRB)
Brain and Nervous System Neuroblastoma Biology Studies (COG ANBL00B1) {CIRB}
Ill-Defined Sites Neuropsychological Functioning in Children Treated for Cancer
Brain and Nervous System ANBL0032: PHASE III RANDOMIZED STUDY OF CHIMERIC ANTIBODY 14.18 (Ch14.18) IN HIGH RISK NEUROBLASTOMA FOLLOWING MYELOABLATIVE THERAPY AND AUTOLOGOUS STEM CELL RESCUE
Leukemia, other A Randomized Open-Label Trial of Caspofungin versus Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML): A Groupwide Phase III Study ( COG ACCLO933) (CIRB)
Leukemia, not otherwise specified A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND#73789, NSC#606869) in the Very Hish Risk Stratum (COG AALL1131)(CIRB)
Myeloid and Monocytic Leukemia AAML1031 A Phase III Randomized Trial for Patients with de novo AML using Bortezomib and Sorafenib (IND#114480; NSC#681239, NSC#724772) for patients with High Allelic Ratio FLT3/ITD; A Groupwide II/III Study
ALTE11C2: Health Effects After Anthracycline and Radiation Therapy (HEART): Dexrazoxane and Preventionof Anthracycline-related Cardiomyopathy
ACCL1034 Impact of Cleansing with Chlorhexidine Gluconate (CHG) on Reducing Central Line Associated Bloodstream Infection (CLABSI) and Acquisition of Multi-drug Resistant Organisms (MDRO) in Children with Cancer or Those Receiving Allogeneic Hematopoietic Cell Transplantation (HCT)
Eye and Orbit ARET12P1 A Multi-institutional Feasibility Study of Intra-Arterial Chemotherapy Given in the Ophthalmic Artery of Children with Retinoblastoma: A Limited Institution Pilot Study
AALL1231 -- A Phase III Randomized Trial Investigating Bortezomib (NSC#681239; IND#58443) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL_ and T-Lymphoblastic Lymphoma (T-LLy) -- A Groupwide Phase III Study

Edit this profile

Contact Info

Nina Kadan-Lottick, MD
Patient Care Location
Yale Pediatric Hematology/OncologySmilow Cancer Hospital at Yale - New Haven
35 Park Street, Ste 7th Floor

New Haven, CT 06511
Office Location
Laboratory for Medicine and Pediatrics
15 York Street, Ste 2073

New Haven, CT 06510
Mailing Address
Yale PediatricsPO Box 208064
New Haven, CT 06520-8064

Curriculum Vitae